Risk factors for peptic ulcer recurrence;Factores de riesgo para la recurrencia de úlcera péptica

Gaceta Medica de Mexico

Volumn 137, Issue 4, 2001, Pages 303-310

  Rodriguez Hernandez H ^a   Jacobo Karam, J S ^a   Guerrero Romero, F ^a  

^a NONE   (Mexico)

Author keywords

Duodenal ulcer; Gastric ulcer; Recurrent ulcer; Risk factors

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL ARTICLE; FEMALE; HELICOBACTER PYLORI; HUMAN; MALE; MEXICO; PEPTIC ULCER; RECURRENT DISEASE; RISK FACTOR; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; RECURRENCE; RISK FACTORS;

EID: 0034883385     PISSN: 00163813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ulcer epidemiology: An overview and proposed research framework
2. Epidemiología de la ulcera péptica en el Instituto Nacional de la Nutrición "Salvador Zubirán"
3. Epidemiología de la úlcera péptica
4. Factores de riesgo clínico para hemorragia y recurrencia de úlcera péptica
5. Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal antiinflammatory drugs
6. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials
7. The problem of gastrointestinal bleeding
8. Factors predisposing to recurrent hemorrhage after acute gastrointestinal bleeding
9. Further hemorrhage after admission to hospital for gastrointestinal bleeding
10. Clinical risk factors
11. Variability in the risk of mayor gastrointestinal complications from nonaspirin nonsteroidal antiinflammatory drugs
12. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer
13. A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer
14. Classification of blood group characteristic secretion pattern
15. Patients with alcohol problems
16. Ulcera péptica en el Hospital de Enfermedades de la Nutrición
17. Ulcera péptica en el anciano
18. Current peptic ulcer time trends. An epidemiologic profile
19. Relative impact of smoking and reduced pulmonary function on peptic ulcer risk
20. Upper GI bleeding in an urban hospital
21. Risk of serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs: A meta-analysis
22. Pathogenesis of peptic ulcer and implications for therapy
23. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs
24. Major upper gastrointestinal tract bleeding: Relation to the use of aspirin and other nonnarcotic analgesics
25. Effects of nonsteroidal antiinflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal antiinflammatory drug-induced damage
26. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease
27. Cimetidine, cigarette smoking, and recurrence of duodenal ulcer
28. Current status of maintenance therapy in peptic ulcer disease
29. RUDER - A prospective, two-year, multicenter study of risk factors for duodenal ulcer relapse during maintenance therapy with ranitidine
30. Recurrence of duodenal ulcer under continuous antisecretory treatment- an approach to the detection of predictive markers
31. Intermittent treatment of duodenal ulcer for long term medical management
32. Prevention of duodenal ulcer recurrence
33. Relationship between Helicobacter pylori eradication and reviews duodenal and gastric ulcers recurrence: A review
34. Bleeding peptic ulcer
35. Ulcer recurrence following duodenal ulcer healing with omeprazol. Ranitidine, or placebo: A double-blind, multicenter, 6-month study
36. H. pylori-negative duodenal ulcer prevalence and causes in 774 patients
37. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal antiinflammatory drugs: A case-control study
38. Randomised trial of eradication of Helicobacter pylori before nonsteroidal antiinflammatory drug therapy to prevent peptic ulcers
39. Neutrophils, Helicobacter pylori, and nonsteroidal antiinflammatory drug ulcers
40. Erradicación de Helicobacter pylori en úlcera péptica y gastritis crónica. Ensayo clínico aleatorio